VKTX
Viking Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Viking Therapeutics has 6 disclosed suppliers and 0 disclosed customers in SEC filings.
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Viking Therapeutics, Inc.
26.99
SentenceAs partial consideration for the grant of the rights and licenses to the Company under the Master License Agreement, the Company issued to Ligand at the closing of the Company's initial public offering ("IPO") 3,655,964 shares of its common stock having an estimated aggregate value of $ 29.2 million.
SentenceOur independent registered public accounting firm, CBIZ CPAs P.C., issued an attestation report on our internal control over financial reporting, as noted below.
VKTX 10-Kaccession 0001193125-26-046876
SentenceIn March 2025, we entered into broad, multi-year manufacturing agreements, or the Manufacturing Agreements, with Corden Pharma Colorado, Inc. and its affiliates, or CordenPharma, covering both the active pharmaceutical ingredient, or API, and final finished product supply for VK2735.
VKTX 10-Kaccession 0001193125-26-046876
SentenceIn March 2025, we entered into broad, multi-year manufacturing agreements, or the Manufacturing Agreements, with Corden Pharma Colorado, Inc. and its affiliates, or CordenPharma, covering both the active pharmaceutical ingredient, or API, and final finished product supply for VK2735.
VKTX 10-Kaccession 0001193125-26-046876
SentenceIn November 2021, the Company entered into an Office Lease (the "Office Lease") with One Pacific Heights. LLC.
VKTX 10-Kaccession 0001193125-26-046876
SentenceIn September 2024 the Company entered into an Office Sublease with TÜV SÜD America Inc. (the "Office Sublease") The Office Sublease is for approximately 6,307 rentable square feet of space located at 9920 Pacific Heights Blvd, Suite 325, San Diego, California 92121 (the "Subleased Premises").
VKTX 10-Kaccession 0001193125-26-046876
—
—
Linked news
Expected move
Inputsspot 27.28exp Feb 19ATM strike 27.5ATM straddle 7.47IV 62%